However, clinical trials have been less conclusive, often showing modest or no improvement in long-term disability indices such as the modified Rankin Scale
INCI Aqua, Glycerin, Glycereth-26, Butylene Glycol, Methylpro Panediol, Vinyl Dimethicone, Niacinamide, 1,2-hexanediol, Betaine, Isononyl Iso Nonanoate, Isohexadecane, Sodium Polyacrylate, Ammonium Acryloyldimethyltaurat/VP Copolymer, Phenyl Trimethicone, Dimethiconol, Perfum, Chondrus Crispus Powder, C18-21 Alkane, Glutathione, Ethylhexylglycerin, Polyglyceryl-10 Laurate, Glyceryl Acrylate/Acrylic Acid Copolymer, Agar, Xanthan Gum, Hydrogenated Lecithin, Polyglyceryl-10 Oleate, Adenosine, Tromethamine, Acrylates/C10-30 Alkyl, Acrylate Crosspolymer, Glucose, Limonene, Gellan Gum, Thioctic Acid, Caprylic/Capric Triglyceride, Citral, Ceramide NP, Sorbitan Laurate, Hydroxyethylcellulose, Acetyl Dipeptide-1 Cetylester, Palmitoyl Tripeptide-5, Acetyl Hexapeptide-1, Soluble Collagen Tips Produkt tylko do uytku zewntrznego
Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, et al
BPC-157 Safety Profile BPC-157 has demonstrated a favorable safety profile in preclinical studies, with no significant toxicity reported even at high doses in animal models (5)
Alternatively, 20mg can be given IV, followed by 3mg/kg per day, given by continuous IV infusion
